Latest Financial Results News

Ten Sixty Four Limited has revealed a staggering net loss of US$43 million for the year ended June 2024, alongside a sharp 94% revenue decline and a modified audit opinion, raising fresh questions about its financial stability.

Argo Investments reports a robust half-year profit of $121.2 million and announces a record fully franked interim dividend of 17.0 cents per share, driven by increased dividend revenue and strategic portfolio moves.

ResMed Inc. reported robust financial results for the quarter ended December 31, 2024, with a 10% increase in net revenue and a 65% jump in net income, driven by strong demand across its Sleep and Breathing Health and Residential Care Software segments.

Yojee's December quarter report reveals solid transaction growth, successful Global Air deployment in Singapore, and promising progress on its MOSAIC platform, supported by a strong cash position and no debt.

Atomos Limited reported a 7% increase in Q2 FY25 sales driven by its core Shinobi II product, but faced margin pressures due to discounting and competitive pricing. The company is finalizing a cost restructure and reviewing funding options to support future growth.

Equinox Resources reports robust quarterly progress across its global portfolio, highlighted by exceptional drill results at Mata da Corda and Alturas, underpinned by a solid $2.2 million cash position.

Harvest Technology Group reported a robust 32% revenue increase and secured strategic partnerships to drive its path to profitability by FY27. The company also raised over $3 million through convertible notes to support expansion efforts.

HALO Technologies reports a robust 45.5% increase in operating revenue for 2024, driven by surging Funds Under Management and brokerage income, while advancing its UK market entry alongside a $6.75 million capital raise.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.

Bindi Metals reports a significant 3.3 km by 0.6 km antimony soil anomaly at its Kreva prospect in Serbia, alongside steady progress on the Lisa Project application and a solid cash position of $1.866 million.

Alexium International Group reports a 16% sales increase in Q2 FY25 despite ongoing mattress market softness, driven by strategic product diversification and supply chain improvements.

Fatfish Group reported a 20% increase in cash receipts to A$0.76 million for Q4 2024, driven by advances in its AI gaming subsidiary, but rising operating expenses led to a net cash outflow of A$0.37 million.